Loading…

Camostat mesilate therapy for COVID-19

Saved in:
Bibliographic Details
Published in:Internal and emergency medicine 2020-11, Vol.15 (8), p.1577-1578
Main Author: Uno, Yoshiharu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803
cites cdi_FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803
container_end_page 1578
container_issue 8
container_start_page 1577
container_title Internal and emergency medicine
container_volume 15
creator Uno, Yoshiharu
description
doi_str_mv 10.1007/s11739-020-02345-9
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2471522776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803</originalsourceid><addsrcrecordid>eNp9UctKxDAUDaI44-gPuJCCIG6iebVJNoLU14AwG3Ub0jaZ6dDHmLTC_L3RjuNj4SLcwD33nHPvAeAYowuMEL_0GHMqISIoPMpiKHfAGEuOoKRJshv-ggiIGOMjcOD9EqE4TjDfByMa4JwxOgZnqa5b3-kuqo0vK92ZqFsYp1fryLYuSmcv0xuI5SHYs7ry5mhTJ-D57vYpfYCPs_tpev0I88DXwZhbRIMIoTFBRYaZYSYTBcmE5gnlVmCqM2kzLm2Rk4wgFIzGObMiSRIrEJ2Aq4F31We1KXLTdE5XauXKWru1anWpfneacqHm7ZviWIigGQjONwSufe2N71Rd-txUlW5M23tFqExouJZkAXr6B7pse9eE9RRhHMeE8GB6AsiAyl3rvTN2awYj9RGDGmJQIQb1GYOSYejk5xrbka-7BwAdAD60mrlx39r_0L4DO0-QPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471522776</pqid></control><display><type>article</type><title>Camostat mesilate therapy for COVID-19</title><source>Springer Nature</source><creator>Uno, Yoshiharu</creator><creatorcontrib>Uno, Yoshiharu</creatorcontrib><identifier>ISSN: 1828-0447</identifier><identifier>EISSN: 1970-9366</identifier><identifier>DOI: 10.1007/s11739-020-02345-9</identifier><identifier>PMID: 32347443</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Animals ; Ce - Letter to the Editor ; Coronavirus Infections - drug therapy ; Coronavirus Infections - epidemiology ; COVID-19 ; Disease Models, Animal ; Gabexate - analogs &amp; derivatives ; Gabexate - standards ; Gabexate - therapeutic use ; Internal Medicine ; Japan ; Medicine ; Medicine &amp; Public Health ; Mesylates - standards ; Mesylates - therapeutic use ; Mice ; Pandemics ; Pneumonia, Viral - drug therapy ; Pneumonia, Viral - epidemiology ; Serine Endopeptidases - standards ; Serine Endopeptidases - therapeutic use</subject><ispartof>Internal and emergency medicine, 2020-11, Vol.15 (8), p.1577-1578</ispartof><rights>Società Italiana di Medicina Interna (SIMI) 2020</rights><rights>Società Italiana di Medicina Interna (SIMI) 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803</citedby><cites>FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32347443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uno, Yoshiharu</creatorcontrib><title>Camostat mesilate therapy for COVID-19</title><title>Internal and emergency medicine</title><addtitle>Intern Emerg Med</addtitle><addtitle>Intern Emerg Med</addtitle><subject>Animals</subject><subject>Ce - Letter to the Editor</subject><subject>Coronavirus Infections - drug therapy</subject><subject>Coronavirus Infections - epidemiology</subject><subject>COVID-19</subject><subject>Disease Models, Animal</subject><subject>Gabexate - analogs &amp; derivatives</subject><subject>Gabexate - standards</subject><subject>Gabexate - therapeutic use</subject><subject>Internal Medicine</subject><subject>Japan</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mesylates - standards</subject><subject>Mesylates - therapeutic use</subject><subject>Mice</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Serine Endopeptidases - standards</subject><subject>Serine Endopeptidases - therapeutic use</subject><issn>1828-0447</issn><issn>1970-9366</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UctKxDAUDaI44-gPuJCCIG6iebVJNoLU14AwG3Ub0jaZ6dDHmLTC_L3RjuNj4SLcwD33nHPvAeAYowuMEL_0GHMqISIoPMpiKHfAGEuOoKRJshv-ggiIGOMjcOD9EqE4TjDfByMa4JwxOgZnqa5b3-kuqo0vK92ZqFsYp1fryLYuSmcv0xuI5SHYs7ry5mhTJ-D57vYpfYCPs_tpev0I88DXwZhbRIMIoTFBRYaZYSYTBcmE5gnlVmCqM2kzLm2Rk4wgFIzGObMiSRIrEJ2Aq4F31We1KXLTdE5XauXKWru1anWpfneacqHm7ZviWIigGQjONwSufe2N71Rd-txUlW5M23tFqExouJZkAXr6B7pse9eE9RRhHMeE8GB6AsiAyl3rvTN2awYj9RGDGmJQIQb1GYOSYejk5xrbka-7BwAdAD60mrlx39r_0L4DO0-QPQ</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Uno, Yoshiharu</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201101</creationdate><title>Camostat mesilate therapy for COVID-19</title><author>Uno, Yoshiharu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Ce - Letter to the Editor</topic><topic>Coronavirus Infections - drug therapy</topic><topic>Coronavirus Infections - epidemiology</topic><topic>COVID-19</topic><topic>Disease Models, Animal</topic><topic>Gabexate - analogs &amp; derivatives</topic><topic>Gabexate - standards</topic><topic>Gabexate - therapeutic use</topic><topic>Internal Medicine</topic><topic>Japan</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mesylates - standards</topic><topic>Mesylates - therapeutic use</topic><topic>Mice</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Serine Endopeptidases - standards</topic><topic>Serine Endopeptidases - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uno, Yoshiharu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal and emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uno, Yoshiharu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Camostat mesilate therapy for COVID-19</atitle><jtitle>Internal and emergency medicine</jtitle><stitle>Intern Emerg Med</stitle><addtitle>Intern Emerg Med</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>15</volume><issue>8</issue><spage>1577</spage><epage>1578</epage><pages>1577-1578</pages><issn>1828-0447</issn><eissn>1970-9366</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32347443</pmid><doi>10.1007/s11739-020-02345-9</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1828-0447
ispartof Internal and emergency medicine, 2020-11, Vol.15 (8), p.1577-1578
issn 1828-0447
1970-9366
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188520
source Springer Nature
subjects Animals
Ce - Letter to the Editor
Coronavirus Infections - drug therapy
Coronavirus Infections - epidemiology
COVID-19
Disease Models, Animal
Gabexate - analogs & derivatives
Gabexate - standards
Gabexate - therapeutic use
Internal Medicine
Japan
Medicine
Medicine & Public Health
Mesylates - standards
Mesylates - therapeutic use
Mice
Pandemics
Pneumonia, Viral - drug therapy
Pneumonia, Viral - epidemiology
Serine Endopeptidases - standards
Serine Endopeptidases - therapeutic use
title Camostat mesilate therapy for COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A02%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Camostat%20mesilate%20therapy%20for%20COVID-19&rft.jtitle=Internal%20and%20emergency%20medicine&rft.au=Uno,%20Yoshiharu&rft.date=2020-11-01&rft.volume=15&rft.issue=8&rft.spage=1577&rft.epage=1578&rft.pages=1577-1578&rft.issn=1828-0447&rft.eissn=1970-9366&rft_id=info:doi/10.1007/s11739-020-02345-9&rft_dat=%3Cproquest_pubme%3E2471522776%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-57f0355623520db14e4eb8d2b8a7637f813ab9fb79fdc2b2003665c4f8666f803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2471522776&rft_id=info:pmid/32347443&rfr_iscdi=true